Influx Healthtech Ltd

Influx Healthtech reports a revenue of INR 1,048.54 million, with a gross profit of INR 401.98 million, translating to a gross margin of 38.34%. The company's operating income is INR 178.45 million, and net income is INR 132.73 million, resulting in a net margin of 12.66%. The company's capital structure is not fully disclosed, but the absence of diluted shares suggests no immediate dilution pressure. The company's profitability metrics, including a net margin of 12.66%, are in line with the industry's preferred metrics for contract development and manufacturing organizations. However, the gross margin of 38.34% is slightly below the median for the Food Processing industry, indicating potential cost pressures or pricing challenges. Influx Healthtech's revenue is concentrated across several segments, including dietary/nutritional supplements, cosmetics, ayurvedic/herbal, veterinary feed supplements, and homecare. The company's geographic exposure is primarily within India, with no disclosed international operations. This concentration may limit diversification benefits and expose the company to regional economic fluctuations. The company's growth trajectory is not explicitly outlined in the latest financial data, but the absence of negative revenue trends and the presence of a positive net income suggest a stable operating environment. The outlook for the current fiscal year is not provided, but the company's ability to maintain profitability indicates a potential for moderate growth. The risk assessment for Influx Healthtech indicates a low dilution risk, with no significant dilution sources identified in the latest filings. However, the liquidity risk could not be assessed due to the lack of balance-sheet inputs and no going-concern language in the source documents. This lack of liquidity data may obscure the company's ability to meet short-term obligations. Recent events and filings for Influx Healthtech do not include significant disclosures about strategic changes, regulatory actions, or major business developments. The company's latest financial snapshot does not provide details on recent events, suggesting a stable but uneventful operational period.